| Identification | Back Directory | [Name]
(E)-Methyl 2-(2-Methoxy-5-((2′,4′,6′-triMethoxystyrylsulfonyl)Methyl)phenylaMino)acetate | [CAS]
592542-61-5 | [Synonyms]
Anticancer agent 9
(E)-2,4,6-TriMethoxystyryl 3-(carboMethoxyMethylaMino)-4-Methoxybenzyl sulfone
(E)-Methyl 2-(2-Methoxy-5-((2′,4′,6′-triMethoxystyrylsulfonyl)Methyl)phenylaMino)acetate
Glycine, N-[2-methoxy-5-[[[(1E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl]methyl]phenyl]-, methyl ester | [Molecular Formula]
C22H27NO8S | [MDL Number]
MFCD12032134 | [MOL File]
592542-61-5.mol | [Molecular Weight]
465.52 |
| Hazard Information | Back Directory | [Uses]
Anticancer agent 9, a glycine derivative, is an anticancer agent. Anticancer agent 9 can inhibit tumor cells viability of myelogenous leukemia and human prostate cancer[1]. | [References]
[1] Pallela VR, et, al. Hydrothiolation of benzyl mercaptan to arylacetylene: application to the synthesis of (E) and (Z)-isomers of ON 01910?Na (Rigosertib?), a phase III clinical stage anti-cancer agent. Org Biomol Chem. 2013 Mar 28;11(12):1964-77. DOI:10.1039/c3ob27220f |
|
|